Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 22686 [2014-09150]

Download as PDF 22686 Federal Register / Vol. 79, No. 78 / Wednesday, April 23, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Time and Date: 1:00 p.m.–5:00 p.m., May 13, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters For Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Addressing Emerging Infectious Diseases in Bangladesh, FOA GH14–002, initial review.’’ Contact Person For More Information: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road, NE., Mailstop D–69, Atlanta, Georgia 30033, Telephone: (404) 639–4796. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. The meeting announced below concerns Conducting Public Health Research in South Africa by the National Health Laboratory Service (NHLS), Funding Opportunity Announcement (FOA) GH12–004; and Strengthening National Capacity in Malaria and Other Infectious Disease Operations Research, FOA GH14–003, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: wreier-aviles on DSK5TPTVN1PROD with NOTICES Time and Date: 10:00 a.m.–12:00 p.m., May 13, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters For Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Conducting Public Health Research in South Africa by the National Health Laboratory Service (NHLS), FOA GH12–004; and Strengthening National Capacity in Malaria and Other Infectious Disease Operations Research, FOA GH14– 003, initial review.’’ Contact Person For More Information: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road, NE., Mailstop D–69, Atlanta, Georgia 30033, Telephone: (404) 639–4796.The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Gary J. Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–09149 Filed 4–22–14; 8:45 am] BILLING CODE 4163–18–P VerDate Mar<15>2010 15:37 Apr 22, 2014 Jkt 232001 The meeting announced below concerns ‘‘Provider Input on Critical Immunization Issues’’, Funding Opportunity Announcement (FOA) IP14–003, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 12:00 p.m.–5:00 p.m., May 13, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters For Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Provider Input on Critical Immunization Issues’’, FOA IP14–003. Contact Person For More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Gary J. Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–09150 Filed 4–22–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Addressing Emerging Infectious Diseases in Bangladesh, Funding Opportunity Announcement (FOA) GH14–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 Gary J. Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–09147 Filed 4–22–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Interagency Committee on Smoking and Health (ICSH) In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces the following meeting of the aforementioned committee. Time and Date: 9:00 a.m.–4:30 p.m., EST, May 13, 2014. Place: Ronald Reagan International Trade Center, Polaris Suite, 1300 Pennsylvania Avenue NW., Washington, DC 20004, Telephone: (202) 312–1300. Status: Open to the public, limited only by the space and telephone lines available. Participants that would like to attend in person are encouraged to register with the contact person listed below. If you will require a sign language interpreter, or have other special needs, please notify the contact person by 4:30 p.m. EST on May 9, 2014. Limited teleconference access is also available. Login information is as follows: E:\FR\FM\23APN1.SGM 23APN1

Agencies

[Federal Register Volume 79, Number 78 (Wednesday, April 23, 2014)]
[Notices]
[Page 22686]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09150]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns ``Provider Input on Critical 
Immunization Issues'', Funding Opportunity Announcement (FOA) IP14-003, 
initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 12:00 p.m.-5:00 p.m., May 13, 2014 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters For Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Provider Input on Critical Immunization Issues'', FOA 
IP14-003.
    Contact Person For More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., 
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Gary J. Johnson,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2014-09150 Filed 4-22-14; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.